HRES 1058 is a non-binding House resolution recognizing the federal government’s duty to develop a Transgender Bill of Rights. It calls for specific policy changes, including amending civil rights laws to explicitly prohibit discrimination based on gender identity in employment, housing, and public accommodations; protecting access to gender-affirming medical care; and streamlining legal recognition of gender identity on federal documents like passports and voter registration. The resolution also proposes expanding protections for transgender and nonbinary individuals in healthcare, education, immigration, and correctional facilities, while emphasizing community-led policy development. As a resolution, it does not create new law but sets a framework for future legislative action.
This symbolic resolution (HRES 172) calls for increased awareness and support for chordoma, a rare bone cancer affecting the skull and spine that impacts over 25,000 people globally and about 300 in the U.S. annually. It urges greater funding for accurate diagnosis, new treatments, faster research-to-treatment pathways, and patient-focused drug development. The resolution does not allocate funds or create new laws but formally expresses the House’s support for addressing chordoma’s challenges. It directly affects chordoma patients, families, and researchers seeking improved care options.
This bill would add wigs (classified as cranial prostheses) to Medicare's coverage of durable medical equipment. It requires a dermatologist, oncologist, or treating physician to certify in writing that a wig is medically necessary due to hair loss caused by conditions like cancer, chemotherapy, or autoimmune diseases. Beneficiaries would need this certification to receive coverage for wigs under Medicare Part B. The change directly affects Medicare beneficiaries experiencing hair loss from these specific medical conditions.
This bill extends a Medicaid payment floor ensuring primary care services (like check-ups and vaccinations) are paid at no less than 100% of Medicare rates for children. It directly affects Medicaid-eligible children by expanding access to care from a broader range of providers, including pediatricians, family doctors, nurse practitioners, certified nurse-midwives, and rural health clinics. Key provisions require managed care plans to meet these payment standards and mandate a study tracking enrollment changes, provider participation, and payment rates across states. The study will compare Medicaid payment rates to Medicare benchmarks and analyze state-level variations over time.
This bill removes the requirement for an initial in-person visit before Medicare beneficiaries can receive mental health services via telehealth. It eliminates geographic restrictions that previously limited telehealth access, allowing services to be provided from home or other locations without travel. The change applies immediately to mental health care and substance use disorder treatment, and permanently removes a 2025 deadline that would have ended expanded telehealth access for rural clinics and health centers. This directly affects Medicare patients seeking mental health support, particularly those in rural areas or with mobility challenges.
This bill modernizes how the FDA inspects facilities manufacturing biosimilar drugs (similar but not identical versions of biologic medicines) in the U.S. It requires the FDA to hold a public meeting and issue a report on expanding international inspection agreements, update inspection tools to increase remote assessments (like virtual site reviews), and develop a strategic plan within a year to address staffing and communication challenges specific to biosimilar facility inspections. The bill directly affects FDA inspectors, biosimilar drug manufacturers, and the FDA's inspection processes for domestic facilities. It focuses on improving inspection efficiency and communication without changing drug approval standards or safety requirements.
The ARCH Act extends Medicare payment protections for rural hospitals through 2031, specifically prolonging the Medicare-Dependent Hospital (MDH) and Medicare Low-Volume Hospital (LVH) programs that prevent payment cuts for financially vulnerable facilities. It requires the GAO to report on rural hospital classifications - including critical access hospitals, rural emergency hospitals, and others - to analyze overlaps and recommend simplifications. The report must also assess how changing cost-reporting rules might improve financial stability for rural hospitals. This bill directly affects rural hospitals qualifying under MDH or LVH designations, ensuring continued Medicare funding until 2031.
HRES 407 is a symbolic House resolution designating May 10, 2025, as "National Asian American, Native Hawaiian, and Pacific Islander Mental Health Day." It directly recognizes the mental health disparities faced by AANHPI communities, including lower service utilization rates and higher youth suicide rates. The resolution encourages federal, state, and local health agencies to improve mental health awareness and access for these communities. It does not create new laws or funding but formally supports efforts to address cultural barriers in mental health care. The designation aligns with May's existing observances of AANHPI Heritage Month and Mental Health Awareness Month.
HRES 224 is a symbolic resolution (not a binding bill) expressing support for recognizing "Detransition Awareness Day." It urges the development of policies ensuring mental health services for people experiencing discomfort with their sex, advocating for informed consent processes about gender-affirming medical procedures, and extending medical malpractice statute of limitations. The resolution also calls for removing damage caps in malpractice claims related to such procedures and requests the Department of Health and Human Services review care guidelines. It has no legal effect but aims to foster public understanding of detransition experiences and promote ethical medical standards.
This bill clarifies that states may use direct primary care arrangements under Medicaid, where patients pay a fixed fee for primary care only (not for other services). It requires the HHS Secretary to issue implementation guidance within one year and submit a report to Congress within two years analyzing state contracting practices and outcomes of these arrangements. The bill directly affects state Medicaid programs and managed care organizations by removing barriers to adopting this payment model. It does not change Medicaid eligibility, funding, or cost-sharing requirements. The focus is on enabling states to explore new primary care delivery methods through clear regulatory guidance.
